课题基金 / 基金详情

PARTIAL HYDROLYSIS PRODUCTS OF PCL5 & POCL3AS POSSIBLE PHOSPHORYLATING AGENTS

PARTIAL HYDROLYSIS PRODUCTS OF PCL5 & POCL3AS POSSIBLE PHOSPHORYLATING AGENTS
PCL5的部分水解产物
批准号:
6258842
负责人:
ROBERT A MITCHELL
金额:
$0.01万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
已结题
起止时间:
1997-06-01 至 1999-11-30

项目摘要

项目成果

ROBERT A MITCHELL的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
POCl3 is a major commercial phosphorylating agent used to synthesize numerous products including biologicals. It has been long recognized that the addition of water to POCl3 dramatically changes its phosphorylating properties although the identity of the active reagent so generated remains uncertain. We have developed a new method for studying the hydrolysis products of PCl5 or POCl3 generated in situ, using limited hydrolysis in 18-O water, followed by complete hydrolysis in normal water. These studies have provided information on the mechanism and kinetics of the in situ hydrolysis process and also revealed the presence of phosphorochloridic acid, H2PO3CL, a hitherto undetected hydrolytic intermediate and a likely candidate as the active phosphorylating reagent in partial hydrolysis mixtures.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Immunotherapeutic targeting of MIF-dependent chaperone activity
  • 批准号:
    10633912
  • 项目类别:
  • 资助金额:
    $35.59万
  • 财政年份:
    2023
  • 负责人:
    ROBERT A MITCHELL
  • 依托单位:
Small molecule targeting of MIF as a novel melanoma therapeutic
  • 批准号:
    8720982
  • 项目类别:
  • 资助金额:
    $31.13万
  • 财政年份:
    2014
  • 负责人:
    ROBERT A MITCHELL
  • 依托单位:
Small molecule targeting of MIF as a novel melanoma therapeutic
  • 批准号:
    9032474
  • 项目类别:
  • 资助金额:
    $31.13万
  • 财政年份:
    2014
  • 负责人:
    ROBERT A MITCHELL
  • 依托单位:
Small molecule targeting of MIF as a novel melanoma therapeutic
  • 批准号:
    9249967
  • 项目类别:
  • 资助金额:
    $31.13万
  • 财政年份:
    2014
  • 负责人:
    ROBERT A MITCHELL
  • 依托单位:
海外基金